But there are a lot of other measures besides the ones Dr. Zamboni did. Like I have heard, there is oxygenation with some form of MRI. There is cognition. The trials seen so far have ways to measure if the procedure succeeded (like DUS), but no measurement of the 'MS' symptoms. We have patient reports, which I think are very important, but my opinion don't carry much weight. We need to somehow measure if there are any concrete improvements. I would think EDSS and QoL would count, but there should be more quantitative measures of things like heat-sensitivity, dizziness, numbness, blindness, etc. These have not been quantitatively measured before and the money supply for measuring these is slim, but they would present a better picture of efficacy. I guess that's one of the reasons Prof. Haacke was suggesting piggy-backing on an annual MRI (some people don't get these, as we know only too well what they will look like). If we find out only some 'MS' symptoms are affected, then we can get into a "symptom war" and see how things shake out.
"Try - Just A Little Bit Harder" - Janis Joplin
CCSVI procedure Albany Aug 2010
'MS' is over - if you want it
Patients sans/without patience